Exploring the effective use of law to achieve Universal Health Coverage
09:30 - 10:30 - Meeting Room 3
Description:
The effective use of law is critical to achieving universal health coverage, just as it is for all other aspects of cancer and noncommunicable disease prevention and control, as well as broader sustainable development goals.
Law occupies a central place in health system design; implementation and governance; the delivery of health care across the life course; and disease prevention and control. Used well, it is among the most powerful enablers of good health practices, better health outcomes and reduced health inequities. Used poorly, it can have a range of negative impacts.
Using practical examples from a number of countries, the aim of this session is to build awareness of the policy decisions and considerations for universal health coverage and to build capacity in the effective use of law to progress universal health coverage and reduce the cancer burden globally.
This session is open to everyone interested in exploring how we can collectively work to ensure that law fulfils its promise. The session will demonstrate that law is not just a matter for lawyers. Engaging with law is essential for everyone working in cancer prevention and control.
Session organised by McCabe Centre for Law & Cancer and UICC, and supported by Cancer Council Australia, Cancer Council Victoria
Public Private Dialogue - Access to cancer medicines: A better way forward
09:30 - 12:00 - Grand Ballroom 3
Panel followed by round table discussion
Description:
A recent analysis of national cancer control plans by UICC showed that delivery of cancer treatment services was not adequately addressed by countries, with a focus predominantly on NCD prevention and early diagnosis and screening of high burden cancers (cervical and breast). With the alarming increase in incidence of cancer cases globally, ignoring the lack of access to treatment for cancer is no longer an option. How can we ensure that cancer treatment reaches the people who need it?
Access to treatment and cancer includes access to cancer medicines and technologies. Barriers to access are created at multiple levels, from Research and Development (R&D) intellectual property rights, supply chain issues and pricing policy frameworks to weak health systems, inadequate infrastructure and lack of human resources.
Fortunately, discussions around these issues are gaining momentum and the topic of access to cancer care is becoming high on the global health agenda for policymakers, civil society and the industry.
Within this context, it is proposed to have a specific session at the WCLS to provide an inclusive multi stakeholder platform to share views, knowledge and data, and have a constructive discussion on how to move forward with the goal of providing better access to cancer treatment. The outcomes of this session will include identification of key barriers, practical steps that each stakeholder can take towards addressing these barriers and the creation of a platform which allows ongoing open, transparent and constructive discussions between stakeholders with the ultimate objective of improving access to treatment and care for cancer patients.
Session supported by ASCP, ESMO, Children Cancer Center of Lebanon, MSD, Novartis and Pfizer Oncology
11:00 - 12:00 - Meeting Room 3
13:30 - 14:30 - Meeting Room 3
As the WHO has noted, “Early detection of cancer greatly increases the chances for successful treatment”. Recognizing the possible warning signs of cancer and taking immediate action leads to early diagnosis and a great chance for successful treatment. And while this “truism” about the importance of screening and early diagnosis has been widely accepted for years, awareness levels remain low and healthcare systems often don’t require – or have the tools or resources – to support a screening program for various types of cancer. Though more acute in lower resource settings or among vulnerable populations, this challenge remains across the globe, regardless of geography, income level, or gender. Why aren’t we doing more? As we aspire to achieve universal healthcare, how can early detection and diagnosis programs become more ingrained in local health systems so we can reduce avoidable deaths and healthcare costs. This expert panel of government, provider, and industry representatives will discuss the critical importance of screening and early diagnosis and a call to action to advance multi-stakeholder engagement to support a set of baseline screening standards in health systems across the globe.
Session supported by Merck Group
13:30 - 14:30 - Grand Ballroom 3
Moderator: Jilly Carter, Former BBC journalist. Carter Communications Ltd (United Kingdom)
Achieving Universal Health Coverage (UHC) by 2030 is one of the targets the nations of the world set in 2015, when they adopted the 2030 Agenda for Sustainable Development. The World Health Organization (WHO) recognises, that efforts towards UHC will enable progress towards other health-related targets, and even towards all the Sustainable Development Goals (SDGs) as “good health allows children to learn and adults to earn, providing the basis for long-term economic development.”
UHC is also tightly linked to the target of prevention and control of non-communicable diseases such as cancers which require an integrated & cross-spectrum global response. Given the complexity of the challenge, a multi-stakeholder approach is critical to expand collaboration across and beyond the healthcare sector.
The UN High Level Meeting (UN HLM) on UHC in September will also have focus on NCDs especially, cancer. As we understand, UHC can be an important vehicle for enhancing population health and reducing inequalities by expanding access to standard of cancer care services. It also provides avenue for increasing national expertise and strengthening of health systems, such as raising disease awareness, accelerating diagnosis, improving healthcare capacity and expanding health financing.
Therefore, as a follow up to the UN HLM, the proposed Panel discussion at WCLS 2019 will help in achieving following objectives:
To bring cancer care at the forefront of achieving UHC:
Session supported by Roche
14:50 - 15:50 - Meeting Room 3
Session sponsored by Roche and Princess Margaret Cancer Center
14:50 - 15:50 - Meeting Room 3
Open discussion including all speakers
Session organised by UICC-WHO
16:00 - 17:00 - Meeting Room 3
The rapid increase in older people worldwide and the expected increase in cancer incidence at older ages will have substantial impacts globally, posing considerable and unique challenges to healthcare systems worldwide.
This session on “Closing the age gap” will seek to raise awareness of the unmet needs and gaps in cancer control in the aging population and establish key challenges and solutions to the main barriers.
Participants will be expected to actively participate in order to share their views and perspective on which topic prioritisation and brainstorm on ideas for progress, with a focus on medical/evidence, policy and public health, education and awareness, and patients and quality of life.
Session supported by Sanofi
16:00 - 17:00 - Grand ballroom 3
Chaired by: Ambassador Sally Cowal, Board Member, Union for International Cancer Control (UICC)
Session organised by UICC
Cervical cancer is a cancer we can prevent and treat. Despite this, in terms of the global cancer burden, this cancer ranks 4th in women, every minute of every day a woman is diagnosed with cervical cancer and 9 or every 10 is a woman living in a low or middle income country.
The global call to action to eliminate cervical cancer, has led to the development of a WHO 2020-2030 global strategy towards elimination of cervical cancer as a public health problem. As we look to this strategy moving to adoption at the World Health Assembly in May 2020, this session will challenge us to consider how we can ensure equity of access to life saving prevention and control services and explore the role that UHC can play in accelerating national elimination.
Building on the earlier session: Supporting priority setting and costing of cancer interventions as part of UHC, this session will review country case studies of working with WHO costing tools to shape national cervical cancer strategies in line with the elimination ambition. Discussions will then be framed around making the case for elimination with three key stakeholder groups: national governments; communities and international development donors.
08:30 – 12:30 - Grand Ballroom 2
No one can predict the future. And yet, the complexities underlying and surrounding life in today’s world point toward disruption, technological change, and a litany of critical uncertainties.
In order to thrive, rather than merely survive, in these “post-normal times” organisations must “use the future” and deploy tactical and strategic approaches to foster learning paradigms based on curiosity, experimentation, and anticipation.
As a widely used approach for building a forward-looking culture, ‘foresight’ provides a rich array of tools, methods, and approaches aimed at enhancing the capacity and capability of leadership to drive organisational transformation.
Organised around three key questions - what’s next? what if? and what now? - this session draws on case studies, research, and gaming aimed at instilling a ‘futures mindset’ in participants.
This programme is supported by MSD
13:30 - 17:30 - Grand Ballroom 2
Understanding and leading transformational change can only be accomplished using effective communications that are tailored to specific cultures. Within today’s complex healthcare environment, both practitioners and patients are influenced by their culture, amplifying the need for cultural understanding and effective communications.
National, organisational, leadership, and professional cultures impact effective leadership, communication, and behaviours. Leaders who pay attention to cultural differences improve the leadership pipeline and the overall quality of healthcare.
This session will review proven data and describe the skills needed by leaders using emotional intelligence as a driver for navigating change within differing languages and cultural barriers. Additionally, the presenters will connect emotional intelligence and cultural awareness to increase leadership effectiveness. The session will end with roundtable discussions to help participants embed these concepts into their leadership practices.
Session organised and delivered by American Society for Clinical Pathology (ASCP)
Exploring the effective use of law to achieve Universal Health Coverage
Regional approaches: Universal Health Coverage and Cancer
Big data, advanced analytics and personalised cancer care
Making the national investment case for cervical cancer elimination
stream